Skip to main content

VBI Vaccines Inc/BC

VBIVDelisted Sep 6, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0000764195

VBI Vaccines Inc/BC was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jul 31, 2023; 41 institutions reported holding it in 13F filings for Q2 2024, worth $1.79M in total; no superinvestor held it.

13F holders, Q1 2025

Institutional positions in VBI Vaccines Inc/BC as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

VBIV is no longer listed, and 13F filings after Q2 2024 list far fewer holders. See Q2 2024

Institutional holders
0
−1 vs. Q4 2024
Shares held
0
−750 (−100.0%) vs. Q4 2024
Total value
$0
$0 vs. Q4 2024
New holders
0
0 more added
Sold out
1
0 more reduced

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VBIV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 0 institutions
Q1 2021: 137 institutionsQ2 2021: 134 institutionsQ3 2021: 126 institutionsQ4 2021: 134 institutionsQ1 2022: 131 institutionsQ2 2022: 131 institutionsQ3 2022: 128 institutionsQ4 2022: 115 institutionsQ1 2023: 96 institutionsQ2 2023: 46 institutionsQ3 2023: 37 institutionsQ4 2023: 39 institutionsQ1 2024: 36 institutionsQ2 2024: 41 institutionsQ3 2024: 1 institutionQ4 2024: 2 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2025: $0
Q1 2021: $376.1MQ2 2021: $384.3MQ3 2021: $347.3MQ4 2021: $260.0MQ1 2022: $191.2MQ2 2022: $83.3MQ3 2022: $69.9MQ4 2022: $36.7MQ1 2023: $27.9MQ2 2023: $7.06MQ3 2023: $1.90MQ4 2023: $1.71MQ1 2024: $1.61MQ2 2024: $1.79MQ3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding VBIV and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20242$0
Q3 20241$0
Q2 202441$1.79M
Q1 202436$1.61M
Q4 202339$1.71M
Q3 202337$1.90M
Q2 202346$7.06M
Q1 202396$27.9M
Q4 2022115$36.7M
Q3 2022128$69.9M
Q2 2022131$83.3M
Q1 2022131$191.2M
Q4 2021134$260.0M
Q3 2021126$347.3M
Q2 2021134$384.3M
Q1 2021137$376.1M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding VBI Vaccines Inc/BC; share changes are against Q4 2024.

Institutions holding VBIV in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Hantz Financial Services, Inc.0$00.00%−750−100.0%Sold out
Financial Gravity Companies, Inc.––––Not filed